Asthma is a frequently experienced chronic inflammatory disease of the airways that is accompanied by symptoms such as coughing, chest tightness, wheezing, shortness of breath, reversible airflow obstruction, and bronchospasm.  This disease is characterized by a variety of symptoms, including forced expiratory volume in 1 second (FEV1) and peak expiratory flow rate.

Research is being conducted to determine how the inflammatory and immune-modulatory properties of adult stem cells can be exploited to control the reactive airways connected with asthma.  The Cell Surgical Network is researching the effects of SVF on chronic asthma.

We apply a treatment plan that includes a combination of intravenous and nebulized SVF delivery.  The treatment is performed under local anesthesia and completed on an outpatient basis.